Comparison of treatment outcomes in community-acquired pneumonia patients treated with beta lactam-macrolide combination versus fluoroquinolone monotherapy

dc.contributor.authorKilinc, O
dc.contributor.authorSoylar, O
dc.contributor.authorCilli, A
dc.contributor.authorSakar, A
dc.contributor.authorTasbakan, S
dc.contributor.authorEllidokuz, H
dc.contributor.authorCelenk, B
dc.contributor.authorCetinkaya, C
dc.contributor.authorGunduz, C
dc.contributor.authorSayiner, A
dc.date.accessioned2025-04-10T10:36:03Z
dc.date.available2025-04-10T10:36:03Z
dc.identifier.e-issn1399-3003
dc.identifier.issn0903-1936
dc.identifier.urihttp://hdl.handle.net/20.500.14701/41962
dc.language.isoEnglish
dc.titleComparison of treatment outcomes in community-acquired pneumonia patients treated with beta lactam-macrolide combination versus fluoroquinolone monotherapy
dc.typeMeeting Abstract

Files